-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Dementias Platform UK: MRC
Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)
Summary The Deep and Frequent Phenotyping Study aims to discover new ways of diagnosing dementia, ideally decades before the symptoms become apparent in order to give future drug treatments the best chance of working. The Deep and Frequent Phenotyping Study … Continue reading →
Posted in Alzheimer's Society, BBC News, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Mental Health, Models of Dementia Care, National, NIHR, Quick Insights, UK, Universal Interest
|
Tagged Ageing Population, Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Amnestic Mild Cognitive Impairment (a-MCI), Amnestic Mild Cognitive Impairment (aMCI), Applications of Big Data, BBC Radio, BBC Radio 4, BBC's World At One Programme, Big Data Analytics, Big Data Funding and Research, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Neuropsychological Test Automated Battery (CANTAB), Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Deep and Frequent Phenotyping Study (DFP), Deep and Frequent Phenotyping; Combinatorial Biomarkers of Dementia, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, DFP Study Team, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Gait and Cognition, Gait Changes, Gateway to Research (GtR), Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, Join Dementia Research, Join Dementia Research: Clinical Trials Matchmaker Service, Join Dementia Research: Recruitment Onto Dementia Studies, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurobiology of Aging (Journal), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Open Data and Big Data, Ophthalmological Assessments, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, PharmaCog Consortium, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Clare Mackay: Imaging Neuroscience at the University of Oxford, Professor Lynn Rochester: Clinical Ageing Research Unit at Newcastle University, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Publicly-Funded UK Big Data Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Screening Tools for Amnestic Mild Cognitive Impairment (a-MCI), Surrogate Biomarkers of Neurodegeneration, Translational Research, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology)
|
Leave a comment
New Drugs for Dementia (POST Note PN 535)
Summary The Parliamentary Office of Science and Technology (POST) has produced a briefing outlining some of the challenges in developing new drugs for dementia, explained in the context of ongoing UK and international research programmes. There is an extensive bibliography, … Continue reading →
Posted in Alzheimer's Society, Alzheimer’s Research UK, Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Models of Dementia Care, National, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest
|
Tagged Academic Institutes in the UK, Academy of Social Sciences, Aducanumab (Biogen), Alzheimer’s Association, Alzheimer’s Research UK’s Drug Discovery Alliance, Behavioural and Psychological Symptoms of Dementia (BPSD), Big Data, Big Data Funding and Research, Big Pharma, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, BPSD: Behavioral and Psychological Symptoms of Dementia, British Psychological Society (BPS), Co-ordination and Data Analytics, Cognitive Health in Ageing Register for Investigations, Collaborative Projects, Collaborative Research, Dementia Consortium, Dementia Risk Prevention, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), DPUK: Dementias Platform UK, Drug Discovery Alliance, Drug Licensing Approval, Drugs for BPSD, Drugs for Cognitive Symptoms of Cognitive Decline and Dementia, EAMS: Early Access to Medicines Scheme, Early Access to Medicines Scheme, Effective Non-Drug Interventions, Etanercept, European Prevention of Alzheimer's Dementia Consortium (EPAD), European Prevention of Alzheimer’s Dementia Consortium, Identification of People At Risk of Dementia, International Collaborations, International Programmes, International Research, Join Dementia Research, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, New Drugs for Dementia (POST Note PN 535), NIHR Clinical Research Network, Observations & Trials in Dementia Research, Parliament, Parliamentary Office of Science & Technology, Parliamentary Office of Science & Technology (POST), Participation in Research, Patient Access to New Drugs, Pharmaceutical Industry, Pioglitazone, POST: Parliamentary Office of Science & Technology, Pre-Symptomatic Diagnosis of Dementia, Preclinical Biomarkers and Dementia, Preclinical Indicators and Dementia, Prevention, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Solanezumab (Eli Lilly), Symptom-Modifying Drugs for Dementia, UK Dementia Research Institute, UK Parliament, UK Patient Recruitment Initiatives, Verubecestat (Merck), Well-Being and Health for People With Dementia (WHELD) Program
|
Leave a comment
Deep and Frequent Phenotyping Study: Dementia Early Detection and Biomarkers Research Programme (MRC / NIHR)
Summary The Deep and Frequent Phenotyping Study will explore improvements in biomarker research and the development of tests to detect Alzheimer’s Disease early on. This research programme will be funded by the National Institute of Health Research (NIHR) and the … Continue reading →
Posted in Alzheimer's Society, Charitable Bodies, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, National, NIHR, Quick Insights, UK, Universal Interest
|
Tagged Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Aridhia, AstraZeneca / MedImmune, Berry Consultants, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Cognition, Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Dr Rob Buckle: Director of Science Programmes at MRC, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Exprodo, Gait and Cognition, Gait Changes, Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, IXICO, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Ophthalmological Assessments, Optos, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Chris Whitty: Chief Scientific Adviser at Department of Health, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Sage Bionetworks, Surrogate Biomarkers of Neurodegeneration, Translational Research, TrialSpark, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology), West London Mental Health Trust / Imperial College London
|
1 Comment
Dementia: the R&D Landscape: Mapping UK Dementia Research and Workforce Capacity (RAND Europe / WDC / OHE)
Summary The Alzheimer’s Society commissioned RAND Europe to analyse the UK’s dementia research “landscape” and workforce capacity. The following report relates to the state of funding and capacity in dementia research. It covers: An audit of the types of research … Continue reading →
Posted in Alzheimer's Society, Charitable Bodies, Commissioning, Diagnosis, End of Life Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, NIHR, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Systematic Reviews, UK, Universal Interest
|
Tagged Active Dementia Researchers: By Sector etc., Alzheimer’s Research UK’s Preparatory Clinical Research Fellowships, Alzheimer’s Society Clinical and Healthcare Professionals Training Fellowships, Amyloid Fibril Formation, Amyloid Hypothesis, Attrition Analysis, Benchmarking, Bibliometric and Citation Analysis of UK Dementia Research, Bibliometric Data, Bibliometric Indicators: Average of Relative Citations (ARCs), Bibliometric Indicators: Average of Relative Impact Factors (ARIFs) - Journals Specialisation Index (SI), Bibliometric Indicators: Growth Ratio (GR), Bibliometric Indicators: Highly Cited Publications (HCPs), Bibliometric Indicators: International Collaboration, Bibliometric Indicators: Number of Papers, Bibliometric Indicators: Transdisciplinarity, Brain Imaging, Centres of Excellence Network in Neurodegeneration (CoEN), Clinical and Technical Expert Group (CTEG), Collaborations for Leadership in Applied Health Research and Care (CLAHRCs), Collaborations for Leadership in Applied Health Research and Care (CLAHRCs)'s Research Capacity in Dementia Care Programme, Dementia Integrated Development Initiative's Clinical and Technical Expert Group (CTEG), Dementia Policy: Research, Dementia R&D Costs: Lower Success Rates and Longer Development Times, Dementia Research, Dementia Research Careers, Dementia Research Funding, Dementia Research Leaders Programme, Dementia Research Priorities, Dementia Research Workforce Pipeline, Dementia Research: UK Impact, Dementia Researchers Workforce Pipeline (Dementia Research), Dementia: the R&D Landscape, Dementia: The R&D Landscape (OHE 2015), Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Department of Health’s Integrated Development Initiative, Disease Modifying Versus Symptom Modifying Treatments (Widespread Mis-Classification in Drugs Development Pipeline), DPUK: Dementias Platform UK, Enabling Dementia Research Careers, Epidemiology, EThOS Database, EU Joint Programme in Neurodegenerative Disease (JPND), EU Joint Programme on Neurodegenerative Disease Research (JPND), EU’s Neurodegenerative Disease Research Joint Programme (JPND), Genetics, Global Context, Imperial College London, Integrated Development, JPND, JPND: Joint Programme on Neurodegenerative Disease Research, Lewy Body Dementia, Mapping of UK Dementia Research and Workforce Capacity, Most Prolific Dementia Researchers: By Field, Most Prolific Dementia Researchers: By Subfield, Office for Health Economics, Office of Health Economics (OHE), OHE: Office of Health Economics, PhD Tracing (Dementia-Related), Pipeline Analysis, Pipeline Databases: European Union Clinical Trials Register, Pipeline Databases: IMS LifeCycle R&D Focus, Pipeline Databases: U.S. National Institutes of Health Database, Psychosocial Interventions, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, RAND Europe, RAND Europe’s Dementia Research Landscape and Workforce Capacity Report (2015), Reasons for Project Discontinuation, Reasons for Successes and Failures of Dementia Treatments, Research Capacity in Dementia Care Programme, Researcher Retention in Dementia Research, Retention of UK Dementia Research Graduates in Dementia Research, Science Metrix, Training and Capacity-Building, UK Dementia Research Topics and Subtopics: Alzheimer’s Disease, UK Dementia Research Topics and Subtopics: Binswanger’s Disease, UK Dementia Research Topics and Subtopics: Cadasil, UK Dementia Research Topics and Subtopics: Early Onset Dementia, UK Dementia Research Topics and Subtopics: Familial Dementia, UK Dementia Research Topics and Subtopics: Frontotemporal Dementia, UK Dementia Research Topics and Subtopics: Late Onset Dementia, UK Dementia Research Topics and Subtopics: Lewy Body Dementia, UK Dementia Research Topics and Subtopics: Logopenic Primary Aphasia, UK Dementia Research Topics and Subtopics: Mild Cognitive Impairment, UK Dementia Research Topics and Subtopics: Other classifications (Syndromes), UK Dementia Research Topics and Subtopics: Pick’s Disease, UK Dementia Research Topics and Subtopics: Post-Stroke Dementia, UK Dementia Research Topics and Subtopics: Posterior Cortical Atrophy, UK Dementia Research Topics and Subtopics: Primary Progressive Aphasia, UK Dementia Research Topics and Subtopics: Primary Progressive Nonfluent Aphasia, UK Dementia Research Topics and Subtopics: Small Vessel Disease, UK Dementia Research Topics and Subtopics: Subcortical Dementia, UK Dementia Research Topics and Subtopics: Subcortical Ischemic Vascular Dementia, UK Dementia Research Topics and Subtopics: Vascular Cognitive Impairment, UK Dementia Research Topics and Subtopics: Vascular Dementia, UK Dementia Research Workforce, UK Dementia Research: Challenges Bottlenecks and Opportunities, UK Dementia Research: Global Perspective, UK Dementia-Related Research, UK Dementia-Related Research Subfields: Biochemistry and Molecular Biology, UK Dementia-Related Research Subfields: Biophysics, UK Dementia-Related Research Subfields: Cardiovascular System and Hematology, UK Dementia-Related Research Subfields: Clinical Psychology, UK Dementia-Related Research Subfields: Developmental Biology, UK Dementia-Related Research Subfields: Endocrinology and Metabolism, UK Dementia-Related Research Subfields: Epidemiology, UK Dementia-Related Research Subfields: Experimental Psychology, UK Dementia-Related Research Subfields: General and Internal Medicine, UK Dementia-Related Research Subfields: General Clinical Medicine, UK Dementia-Related Research Subfields: General Science and Technology, UK Dementia-Related Research Subfields: Genetics and Heredity, UK Dementia-Related Research Subfields: Geriatrics, UK Dementia-Related Research Subfields: Gerontology, UK Dementia-Related Research Subfields: Health Policy and Services, UK Dementia-Related Research Subfields: Immunology, UK Dementia-Related Research Subfields: Medicinal and Biomolecular Chemistry, UK Dementia-Related Research Subfields: Microbiology, UK Dementia-Related Research Subfields: Neurology and Neurosurgery, UK Dementia-Related Research Subfields: Nuclear Medicine and Medical Imaging, UK Dementia-Related Research Subfields: Nursing, UK Dementia-Related Research Subfields: Nutrition and Dietetics, UK Dementia-Related Research Subfields: Oncology and Carcinogenesis, UK Dementia-Related Research Subfields: Organic Chemistry, UK Dementia-Related Research Subfields: Pathology, UK Dementia-Related Research Subfields: Pharmacology and Pharmacy, UK Dementia-Related Research Subfields: Psychiatry, UK Dementia-Related Research Subfields: Public Health, UK Dementia-Related Research Subfields: Rehabilitation, UK Dementia-Related Research Subfields: Virology, UK Spending on Dementia Research, WDC: World Dementia Council, Workforce, Workforce Development, Workforce Issues, Workforce Planning, World Dementia Council
|
Leave a comment
Definitive and Comprehensive List of Dementia-Related Internet Sites: Updated (CILIP / HLG)
Summary The CILIP Health Libraries Group (HLG) has released an updated list of dementia-related websites, whether based in the UK or internationally. This latest update strives to supply a definitive and complete list of trustworthy and authoritative online information sources. … Continue reading →
Posted in Acute Hospitals, Age UK, Alzheimer's Research Trust, Alzheimer's Society, Alzheimer’s Disease International (ADI), Alzheimer’s Research UK, Charitable Bodies, Community Care, Department of Health, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Management of Condition, Mental Health, Mental Health Foundation, Models of Dementia Care, NHS Digital (Previously NHS Choices), Quick Insights, RCN, Royal College of Psychiatrists, SCIE, Scotland, UK, Universal Interest
|
Tagged Alzheimer Scotland, Alzheimer's Society, AT Dementia, Books on Prescription, CILIP Health Libraries Group, CILIP Health Libraries Group Newsletter, Clinical Knowledge Summaries: Dementia, Dementia Action Alliance (DAA), Dementia Centre: University of Stirling, Dementia Friends, Dementia Friends Programme, Dementia Gateway, Dementia Institute: Bournemouth University, Dementia Research Centre: National Hospital for Neurology and Neurosurgery, Dementia Research Centre: University College London, Dementia Service Development Centre: University of Stirling, Dementia Services Development Centre (University of Stirling), Dementia-Related Information Resources, Dementia-Related Internet Sites, Dementia-Related Websites, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Department of Health Dementia Challenge, DPUK: Dementias Platform UK, Genes and Disease: The Nervous System, Guardian, Health Information, Health Libraries Group (HLG), Join Dementia Research, Joseph Rowntree Foundation, Keith Nockels: Librarian at University of Leicester (HLG), MedGen (NLM Portal), National Hospital for Neurology and Neurosurgery: UCL Institute of Neurology, NCBI Bookshelf, Neurosurgic, NHNN: National Hospital for Neurology and Neurosurgery, NHS Evidence, NICE: Dementia Guide, NIHR Biomedical Research Unit for Dementia, OMIM: Genetic Testing Registry and Gene Reviews, Royal College of Nursing: Dementia, SCIE Dementia Gateway, Scottish Dementia Working Group, Skills for Care, University of California San Francisco: Memory and Aging Center, University of Stirling's Dementia Services Development Centre
|
Leave a comment
